Baseline serum CXCL10 and IL-12 levels may predict severe asthmatics' responsiveness to omalizumab.
| Image |  |
|---|---|
| Description | scientific article published on 5 December 2017 |
| Author/s |
author: Nobuharu Ohshima |
| Publication date | December 5, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |